ABERNETHY MATT
Insider CIK 1724097 · FATE Director · NBIX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-09-14 | 2026-09-15 | 2,311 | $157.20 | $363.3K | 42,808 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-09-14 | 2026-09-15 | 2,311 | $157.20 | $363.3K | 42,808 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 5,020 | — | $0 | 47,828 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 2,709 | $156.22 | $423.2K | 45,119 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 2,709 | $156.22 | $423.2K | 45,119 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 5,020 | — | $0 | 47,828 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2026-06-12 | 2026-06-15 | 87,900 | — | $0 | 87,900 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | G Gift | 2026-03-04 | 2026-03-05 | 2,249 | — | $0 | 42,808 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 7,735 | — | $0 | 7,735 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 44,095 | — | $0 | 44,095 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 2,241 | — | $0 | 4,484 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 2,566 | — | $0 | 2,566 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 2,241 | — | $0 | 40,320 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 1,210 | $124.12 | $150.2K | 39,110 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 5,378 | $124.12 | $667.5K | 44,881 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-02-13 | 2026-02-17 | 9,968 | — | $0 | 50,259 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 1,385 | $124.12 | $171.9K | 40,291 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 2,566 | — | $0 | 41,676 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-12 | 2026-02-17 | 2,133 | — | $0 | 6,401 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-12 | 2026-02-17 | 1,151 | $123.10 | $141.7K | 38,079 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-12 | 2026-02-17 | 2,133 | — | $0 | 39,230 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-01-31 | 2026-02-03 | 2,437 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-01-31 | 2026-02-03 | 2,437 | — | $0 | 38,465 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-01-31 | 2026-02-03 | 1,368 | $136.06 | $186.1K | 37,097 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2025-05-29 | 2025-05-30 | 110,000 | — | $0 | 110,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 2,241 | — | $0 | 6,725 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 2,566 | — | $0 | 5,132 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 1,206 | $116.87 | $140.9K | 35,810 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 2,241 | — | $0 | 37,016 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 1,352 | $116.85 | $158.0K | 34,775 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 2,566 | — | $0 | 36,127 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 45,538 | — | $0 | 45,538 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 8,534 | — | $0 | 8,534 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-10 | 2025-02-12 | 980 | $118.27 | $115.9K | 33,561 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-08 | 2025-02-12 | 1,860 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-08 | 2025-02-12 | 1,860 | — | $0 | 34,541 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-01-31 | 2025-02-04 | 2,436 | — | $0 | 2,437 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-01-31 | 2025-02-04 | 1,283 | $152.87 | $196.1K | 32,681 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-01-31 | 2025-02-04 | 2,436 | — | $0 | 33,964 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-08-13 | 2024-08-15 | 14,100 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-08-13 | 2024-08-15 | 14,100 | $150.38 | $2.12M | 31,528 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-08-13 | 2024-08-15 | 14,100 | $73.60 | $1.04M | 45,628 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-07-16 | 2024-07-18 | 900 | — | $0 | 14,100 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-07-16 | 2024-07-18 | 900 | $73.60 | $66.2K | 32,428 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-07-16 | 2024-07-18 | 900 | $150.04 | $135.0K | 31,528 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-15 | 2024-05-16 | 15,000 | $73.60 | $1.10M | 15,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-15 | 2024-05-16 | 15,000 | $73.60 | $1.10M | 46,528 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-05-15 | 2024-05-16 | 15,000 | $140.24 | $2.10M | 31,528 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-14 | 2024-05-16 | 15,000 | $73.60 | $1.10M | 30,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-14 | 2024-05-16 | 15,000 | $73.60 | $1.10M | 46,528 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-05-14 | 2024-05-16 | 15,000 | $135.66 | $2.03M | 31,528 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 8,966 | — | $0 | 8,966 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 45,058 | — | $0 | 45,058 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-13 | 2024-02-15 | 1,352 | $132.85 | $179.6K | 31,528 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-08 | 2024-02-08 | 980 | $134.21 | $131.5K | 30,314 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-06 | 2024-02-08 | 1,280 | $142.19 | $182.0K | 29,434 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-01-31 | 2024-02-02 | 1,283 | $140.72 | $180.5K | 28,284 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-08-21 | 2023-08-23 | 2,132 | $107.39 | $229.0K | 27,131 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 10,264 | — | $0 | 10,264 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 63,789 | — | $0 | 63,789 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-08 | 2023-02-08 | 980 | $104.19 | $102.1K | 25,213 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 12,807 | $102.42 | $1.31M | 35,824 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 11,491 | $102.40 | $1.18M | 24,333 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 2,030 | $102.33 | $207.7K | 24,333 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-06 | 2023-02-08 | 1,280 | $105.67 | $135.3K | 22,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-31 | 2023-02-02 | 1,283 | $109.98 | $141.1K | 21,357 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-08 | 2022-02-09 | 980 | $79.65 | $78.1K | 20,204 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 1,280 | $80.78 | $103.4K | 19,325 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 2,030 | $80.80 | $164.0K | 18,175 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 66,362 | — | $0 | 66,362 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 9,745 | — | $0 | 9,745 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-12-01 | 2021-12-03 | 1,645 | $82.59 | $135.9K | 16,349 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-02-09 | 7,439 | — | $0 | 7,439 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-02-09 | 44,632 | — | $0 | 44,632 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-03-26 | 49,049 | — | $0 | 49,049 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 880 | $116.85 | $102.8K | 13,043 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 2,030 | $116.81 | $237.1K | 14,869 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-12-01 | 2020-12-02 | 1,645 | $94.66 | $155.7K | 11,494 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-11-12 | 2020-11-16 | 2,257 | $90.74 | $204.8K | 10,014 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-08-05 | 2020-08-07 | 2,257 | $118.90 | $268.4K | 7,983 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2020-05-07 | 2020-05-11 | 15,000 | $73.60 | $1.10M | 45,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-05-07 | 2020-05-11 | 15,000 | $110.21 | $1.65M | 5,953 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2020-05-07 | 2020-05-11 | 15,000 | $73.60 | $1.10M | 20,953 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-04-28 | 2020-04-30 | 1,741 | $102.49 | $178.4K | 5,953 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-04-24 | 2020-04-28 | 1,934 | $99.52 | $192.5K | 7,694 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-07 | 2020-02-11 | 2,030 | $103.35 | $209.8K | 5,701 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-02-06 | 2020-02-07 | 61,347 | — | $0 | 61,347 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-02-06 | 2020-02-07 | 9,719 | — | $0 | 9,719 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-12-02 | 2019-12-04 | 1,645 | $116.33 | $191.4K | 3,876 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-02-07 | 2019-02-08 | 83,341 | — | $0 | 83,341 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-02-07 | 2019-02-08 | 15,423 | — | $0 | 15,423 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-12-03 | 2018-12-06 | 1,178 | $90.00 | $106.0K | 1,947 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 12,250 | — | $0 | 12,250 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 12,250 | — | $0 | 12,250 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-12-01 | 2017-12-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-12-01 | 2017-12-05 | 60,000 | — | $0 | 60,000 | SEC↗ |